Skip to content

Clinical trials

Phase 3 Adenocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20071
20093
20102
20111
20142
20163
20182
20192
20211
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Active, not recruiting3
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.4
AstraZeneca2
Australasian Gastro-Intestinal Trials Group2
Eli Lilly and Company2
Abbott1
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Canadian Cancer Trials Group1
Celgene1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma25
Neoplasms8
Carcinoma6
Digestive System Neoplasms5
Stomach Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Digestive System Diseases4
Neoplasm Metastasis4
Neoplasms by Site4
Neoplasms by Histologic Type3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.